Cargando…

Intranasal Delivery of RIG-I Agonist Drives Pulmonary Myeloid Cell Activation in Mice

Viral respiratory infections cause substantial health and economic burden. There is a pressing demand for efficacious vaccination strategies and, therefore, a need for a better understanding of the mechanisms of action of novel potential adjuvants. Here we investigated the effect of a synthetic RIG-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nair, Sajith, Wu, Yilun, Nguyen, Trinh Mai, Fink, Katja, Luo, Dahai, Ruedl, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241514/ https://www.ncbi.nlm.nih.gov/pubmed/35784329 http://dx.doi.org/10.3389/fimmu.2022.910192

Ejemplares similares

Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
por: Peng, Boya, et al.
Publicado: (2022)

Microbiota regulates the turnover kinetics of gut macrophages in health and inflammation
por: Chen, Qi, et al.
Publicado: (2021)

RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections
por: Yong, Hui Yee, et al.
Publicado: (2018)

RIG-I agonist SLR10 promotes macrophage M1 polarization during influenza virus infection
por: Wu, Wenxin, et al.
Publicado: (2023)

Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium
por: Teixeira, Ana Rafaela, et al.
Publicado: (2022)

Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
por: Brisse, Morgan, et al.
Publicado: (2019)

Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5
por: Reikine, Stephanie, et al.
Publicado: (2014)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

Memory Inflation Drives Tissue-Resident Memory CD8(+) T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
por: Morabito, Kaitlyn M., et al.
Publicado: (2018)

Analysis of Porcine RIG-I Like Receptors Revealed the Positive Regulation of RIG-I and MDA5 by LGP2
por: Li, Shuangjie, et al.
Publicado: (2021)

Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses
por: Jiang, Xiaodong, et al.
Publicado: (2019)

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
por: Bošnjak, Berislav, et al.
Publicado: (2021)

Human metapneumovirus M2-2 protein inhibits RIG-I signaling by preventing TRIM25-mediated RIG-I ubiquitination
por: Tanaka, Yukie, et al.
Publicado: (2022)

Cooperation between cGAS and RIG-I sensing pathways enables improved innate recognition of HIV-1 by myeloid dendritic cells in elite controllers
por: Martin-Gayo, Enrique, et al.
Publicado: (2022)

Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2
por: Nguyen, Khue G., et al.
Publicado: (2022)

Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity
por: Liu, Yiliu, et al.
Publicado: (2017)

Regulation of RIG-I Activation by K63-Linked Polyubiquitination
por: Okamoto, Masaaki, et al.
Publicado: (2018)

Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants
por: Lässig, Charlotte, et al.
Publicado: (2018)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022)

Comparative analysis of viral RNA signatures on different RIG-I-like receptors
por: Sanchez David, Raul Y, et al.
Publicado: (2016)

Editorial: Updates on RIG-I-like receptor-mediated innate immune responses
por: Kishore, Uday, et al.
Publicado: (2023)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2023)

Thermoreversible Biogels for Intranasal Delivery of Rizatriptan Benzoate
por: Chand, Renuka, et al.
Publicado: (2009)

Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses
por: Liu, Wei, et al.
Publicado: (2017)

NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I Signaling
por: Li, Aixin, et al.
Publicado: (2020)

Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment
por: Wong, Sze Wing, et al.
Publicado: (2022)

Defining the functional determinants for RNA surveillance by RIG-I
por: Kohlway, Andrew, et al.
Publicado: (2013)

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
por: Du, Yue, et al.
Publicado: (2022)

Interaction With 14-3-3 Correlates With Inactivation of the RIG-I Signalosome by Herpesvirus Ubiquitin Deconjugases
por: Gupta, Soham, et al.
Publicado: (2020)

Immune Regulator Retinoic Acid-Inducible Gene I (RIG-I) in the Pathogenesis of Cardiovascular Disease
por: Wang, Hao, et al.
Publicado: (2022)

Type 1 Conventional CD103(+) Dendritic Cells Control Effector CD8(+) T Cell Migration, Survival, and Memory Responses During Influenza Infection
por: Ng, See Liang, et al.
Publicado: (2018)

Factors affecting RIG-I-Like receptors activation - New research direction for viral hemorrhagic fevers
por: Małkowska, Paulina, et al.
Publicado: (2022)

Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177(+) Neutrophils
por: Seo, Dong Hyuk, et al.
Publicado: (2021)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity
por: Ho, Victor, et al.
Publicado: (2019)

Latent Membrane Protein 1 of Epstein–Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway
por: Xu, Chongfeng, et al.
Publicado: (2018)

Molecular Mechanisms for the Adaptive Switching Between the OAS/RNase L and OASL/RIG-I Pathways in Birds and Mammals
por: Rong, Enguang, et al.
Publicado: (2018)

Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation
por: Fekete, Tünde, et al.
Publicado: (2018)

NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
por: Khan, Arshad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_75m5u6ut9n0oep2glm7lte3la6